Malignancy outcomes and the impact of repeat fine needle aspiration of thyroid nodules with Bethesda category III cytology: A multicenter experience-Reference-Cited by-同舟云学术

Malignancy outcomes and the impact of repeat fine needle aspiration of thyroid nodules with Bethesda category III cytology: A multicenter experience

Published:2021-07 Issue:10 Volume:49 Page:1110-1115
ISSN:8755-1039
Container-title:Diagnostic Cytopathology
language:en
Short-container-title:Diagnostic Cytopathology

Author:

Köseoğlu Derya¹^ORCID,Özdemir Başer Özden²^ORCID,Çetin Zeynep³^ORCID

Affiliation:

1. Faculty of Medicine, Department of Endocrinology and Metabolism Hitit University Çorum Turkey

2. Department of Endocrinology and Metabolism Yozgat State Hospital Yozgat Turkey

3. Faculty of Medicine, Department of Endocrinology and Metabolism Amasya University Amasya Turkey

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dc.24823

Reference21 articles.

1. The Bethesda System for Reporting Thyroid Cytopathology

2. The 2017 Bethesda System for Reporting Thyroid Cytopathology

3. Malignancy rates in thyroid nodules classified as Bethesda categories III and IV: retrospective data from a tertiary center;Godoi Cavalheiro B;Int J Endocrinol Metab,2018

4. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

5. The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRAF Detection in FNAC Combined with Semi-Quantitative 99mTc-MIBI Technique and AI Model, an Economic and Efficient Predicting Tool for Malignancy in Thyroid Nodules;Diagnostics;2024-06-30

2. Cytologic assessment of thyroid nodules – Updates in 2023 Bethesda reporting system, diagnostic challenges and pitfalls;Human Pathology Reports;2024-06

3. Performance of Afirma genomic sequencing classifier and histopathological outcome in Bethesda category III thyroid nodules: Initial versus repeat fine‐needle aspiration;Diagnostic Cytopathology;2023-07-31

4. Overview of Diagnostic Terminology and Reporting;The Bethesda System for Reporting Thyroid Cytopathology;2023

5. Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS;Cancers;2022-09-16